Xconomy.com -- Amylin Pharmaceuticals’ board of directors has unanimously elected former Novartis CEO Paulo Costa as chairman, an appointment that was supported by Eastbourne Capital Management of San Rafael, CA, an institutional investor that had voiced concerns about the vacancy in the chairman’s role.
